SCHEMBL17218110

SCHEMBL17218110

Cc1ccc(CON=[C]c2cccc(Br)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 9/20 0.52
▸ ALDH1A1 P00352 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MAPK1 P28482 1/20 0.37
▸ CCR5 P51681 1/20 0.35
▸ AGXT P21549 4/20 0.35
▸ IDO1 P14902 2/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ MAOA P21397 1/20 0.34
▸ HTR7 P34969 1/20 0.34
▸ HTR6 P50406 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17218107 1.00 MAOB (0.52) MAOBALDH1A1NPC1LMNACYP1A2
SCHEMBL17217382 0.89 MAOB (0.39) MAOBNPC1LMNARAB9AAGXT
SCHEMBL17217381 0.89 MAOB (0.39) MAOBNPC1LMNARAB9AAGXT
SCHEMBL17216860 0.87 MAOB (0.44) MAOBALDH1A1NPC1CYP1A2CYP3A4
SCHEMBL17216862 0.87 MAOB (0.44) MAOBALDH1A1NPC1CYP1A2CYP3A4
SCHEMBL17218950 0.87 MAOB (0.54) MAOBALDH1A1MAPK1CCR5AGXT
SCHEMBL17218953 0.87 MAOB (0.54) MAOBALDH1A1MAPK1CCR5AGXT
SCHEMBL17217973 0.87 MAOB (0.49) MAOBAGXTIDO1
SCHEMBL17217972 0.87 MAOB (0.49) MAOBAGXTIDO1
SCHEMBL17216540 0.87 RAB9A (0.40) MAOBNPC1MAPTRAB9AAGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940012-B1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-30 — — EP disclosed
US-9560850-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-07 — — US disclosed
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 — — US disclosed
EP-2940012-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF Sumitomo Chemical Company Limited (JP) 2015-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF RTN3, CYP51A1, TCOF1 MAOB 3611/4885ALDH1A1 2300/4885NPC1 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback